VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

OKYO Pharma Limited (OKYO) Total Return Calculator with Dividends Reinvested

OKYO Pharma Limited

Popular:

The total return for OKYO Pharma Limited (OKYO) stock is +10.20% over the past 12 months. So far it's down 27.35% this year. The 5-year total return is -55.25%, meaning $10,000 invested in OKYO stock 5 years ago would be worth $4,475 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in OKYO 1 year ago, it would be worth $10,946 today — you'd have gained $946.

With Dividends Reinvested$10,946+9.46%

Price Only (No DRIP)$10,946+9.46%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in OKYO

1Y$11,020+$1,020 (+10.2%)10.2% CAGR

3Y$7,606-$2,394 (-23.9%)-8.7% CAGR

5Y$4,475-$5,525 (-55.2%)-14.9% CAGR

10Y$4,475-$5,525 (-55.2%)-7.7% CAGR

15Y$4,475-$5,525 (-55.2%)-5.2% CAGR

20Y$4,475-$5,525 (-55.2%)-3.9% CAGR

30Y$4,475-$5,525 (-55.2%)-2.6% CAGR

OKYO Pharma Limited did not pay dividends during this period. Total return = price return.

Loading OKYO total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-27.35%	—	-27.35%	—	$7,265
1Y	+10.20%	10.20%	+10.20%	—	$11,020
3Y	-23.94%	-8.72%	-23.94%	—	$7,606
5Y	-55.25%	-14.85%	-55.25%	—	$4,475
10Y	-55.25%	-7.73%	-55.25%	—	$4,475
15Y	-55.25%	-5.22%	-55.25%	—	$4,475
20Y	-55.25%	-3.94%	-55.25%	—	$4,475
30Y	-55.25%	-2.64%	-55.25%	—	$4,475

Risk & Highlights

Best Year+83.19%2025

Worst Year-47.24%2022

Max Drawdown-53.82%2025-08-08 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-23.32%	-23.32%	—	+0.41%	-23.7pp
2025	+83.19%	+83.19%	—	+16.64%	+66.5pp
2024	-40.72%	-40.72%	—	+24.00%	-64.7pp
2023	-11.50%	-11.50%	—	+24.81%	-36.3pp
2022	-47.24%	-47.24%	—	-19.95%	-27.3pp

OKYO underperformed the S&P 500 by 20.17pp over the past year (+10.20% vs +30.37%).

Loading summary...

OKYO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
OKYOOKYO Pharma Limited	$66M	+0.0%	-27.4%	+10.2%	—	-23.9%	-55.2%	-55.2%
LNTHLantheus Holdings, Inc.	$5.9B	+16.5%	+35.3%	+13.1%	—	-4.0%	+314.2%	+4192.5%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
SGHTSight Sciences, Inc.	$286M	+51.1%	-29.3%	+85.0%	—	-49.7%	-84.2%	-84.2%
AVXLAnavex Life Sciences Corp.	$289M	+1.3%	-15.2%	-63.2%	—	-62.9%	-72.4%	-25.7%
ALDXAldeyra Therapeutics, Inc.	$104M	+13.8%	-63.0%	-13.9%	—	-83.8%	-86.1%	-72.1%
HALOHalozyme Therapeutics, Inc.	$7.7B	+2.5%	-7.3%	-7.1%	—	+115.3%	+37.0%	+570.7%
TARSTarsus Pharmaceuticals, Inc.	$2.7B	-7.0%	-20.8%	+35.1%	—	+310.3%	+113.3%	+210.8%
PRPHProPhase Labs, Inc.	$5M	+41.0%	-66.7%	-58.0%	—	-97.1%	-63.2%	+37.5%
ALNYAlnylam Pharmaceuticals, Inc.	$39.5B	-7.4%	-26.1%	+7.0%	—	+40.9%	+125.4%	+411.9%
REGNRegeneron Pharmaceuticals, Inc.	$73.7B	-6.7%	-8.5%	+27.1%	+0.6pp	-5.1%	+43.6%	+90.0%

Compare:OKYO vs LNTH OKYO vs NVCR OKYO vs SGHT OKYO vs LNTH vs NVCR

About OKYO Dividend Returns

OKYO Pharma Limited (OKYO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of OKYO over the past year?

OKYO Pharma Limited (OKYO) delivered a return of 10.20% over the past year. Since OKYO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in OKYO be worth today?

A $10,000 investment in OKYO Pharma Limited one year ago would be worth $11,020 today, representing a gain of $1,020.

Q3Does OKYO pay dividends?

OKYO Pharma Limited (OKYO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For OKYO, the total return equals the price-only return.

Q4Did OKYO beat the S&P 500?

No, OKYO Pharma Limited (OKYO) underperformed the S&P 500 by 20.17 percentage points over the past year. OKYO delivered a total return of 10.20%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed OKYO by 20.17pp during this period.

Q5What is OKYO's worst drawdown?

OKYO Pharma Limited (OKYO) experienced a maximum drawdown of -53.82% over the past year, declining from its peak on 2025-08-08 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is OKYO's long-term total return over 10, 20, or 30 years?

Here are OKYO Pharma Limited (OKYO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -55.2% (-7.7% CAGR) — $10,000 would have grown to $4,475. Over 20 years: -55.2% total return (-3.9% CAGR) — $10,000 → $4,475. Over 30 years: -55.2% total return (-2.6% CAGR) — $10,000 → $4,475. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was OKYO's best and worst year?

OKYO Pharma Limited's best calendar year was 2025 with a total return of 83.2%. Its worst year was 2022 with a total return of -47.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 130.4 percentage points.